Kenshi Suzuki¹, Shinsuke Iida², Hirohiko Shibayama³, Thierry Facon⁴, Nizar Bahlis⁵, Saad Z Usmani⁶, Hiroshi Yamazaki⁷, Hiromi Koga⁷, Akiko Suzuki⁷, Jianping Wang⁸, Rian Van Rampelbergh⁹, Hiroyuki Takamatsu¹⁰ (1.Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan, 2.Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 3.Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan, 4.Service des Maladies du Sang, Hopital Claude Huriez, Lille, France Metropolitan, 5.University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, Alberta, Canada, 6.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America, 7.Janssen Pharmaceutical K.K., Research & Development Division, Tokyo, Japan, 8.Janssen Research & Development, Raritan, NJ, United States of America, 9.Janssen Research & Development, Beerse, Kingdom of Belgium, 10.Hematology/Respiratory Medicine, Kanazawa University, Kanazawa, Japan)

Nizar J. Bahlis¹, Aurore Perrot², Thierry Facon³, Torben Plesner⁴, Saad Z Usmani⁵, Shaji Kumar⁶, Karthik Ramasamy⁷, Murielle Roussel⁸, Carla Araujo⁹, Arnaud Jaccard¹⁰, Michel Delforge¹¹, Jianping Wang¹², Rachel Kobos¹², Caroline McKay¹², Katharine S. Gries¹², Jeremiah Trudeau¹², Cyrille Hulin¹³, Katja Weisel¹⁴ (1.University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada, 2.Hematology Department, University Hospital, Vandoeuvre Les Nancy, France Metropolitan, 3.Service des Maladies du Sang, Hopital Claude Huriez, Lille, France Metropolitan, 4.Vejle Hospital and University of Southern Denmark, Vejle, Kingdom of Denmark, 5.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America, 6.Department of Hematology, Mayo Clinic Rochester, Rochester, MN, United States of America, 7.Oxford University Hospital and NIHR BRC Blood Theme, Oxford, United Kingdom of Great Britain and Northern Ireland, 8.CHU Purpan/IUCT Oncopole, Toulouse, France Metropolitan, 9.Centre Hospitalier de la Cote Basque, Bayonne, France Metropolitan, 10.Centre Hospitalier Universitaire, Limoges, France Metropolitan, 11.Department of Hematology, University Hospital Leuven, Leuven, Kingdom of Belgium, 12.Janssen Global Services, Raritan, NJ, United States of America, 13.Department of Hematology, Hospital Haut Leveque, University Hospital, Pessac, France Metropolitan, 14.Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Federal Republic of Germany)

Nizar J. Bahlis¹, Saad Z. Usmani², Thierry Facon³, Shaji Kumar⁴, Torben Plesner⁵, Philippe Moreau⁶, Supratik Basu⁷, Hareth Nahi⁸, Margaret Macro⁹, Hang Quach¹⁰, Aurore Perrot¹¹, Christopher P. Venner¹², Katja Weisel¹³, Noopur Raje¹⁴, Michel Attal¹⁵, Xavier Leleu¹⁶, Maria Krevvata¹⁷, Jianping Wang¹⁸, Rachel Kobos¹⁸, Cyrille Hulin¹⁹ (1.University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada, 2.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America, 3.Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France Metropolitan, 4.Department of Hematology, Mayo Clinic Rochester, Rochester, MN, United States of America, 5.Vejle Hospital and University of Southern Denmark, Vejle, Kingdom of Denmark, 6.Hematology, University Hospital Hôtel-Dieu, Nantes, France Metropolitan, 7.Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom of Great Britain and Northern Ireland, 8.Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Kingdom of Sweden, 9.Centre Hospitalier Universitaire (CHU) de Caen, Caen, France Metropolitan, 10.St. Vincent's Hospital, University of Melbourne, Melbourne, Australia, 11.Hematology Department, University Hospital, Vandoeuvre Les Nancy, France Metropolitan, 12.Division of Medical Oncology University of Alberta, Edmonton, AB, Canada, 13.Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Federal Republic of Germany, 14.Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, United States of America, 15.Service d'Hématologie, CHU de Toulouse-Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France Metropolitan, 16.Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France Metropolitan, 17.Janssen Research & Development, Spring House, PA, United States of America, 18.Janssen Research & Development, Raritan, NJ, United States of America, 19.Department of Hematology, Hospital Haut Leveque, University Hospital, Pessac, France Metropolitan)

Shinsuke Iida¹, Jonathan L. Kaufman², Meletios A. Dimopoulos³, Merav Leiba⁴, P Joy Ho⁵, Kihyun Kim⁶, Philippe Moreau⁷, Heather J Sutherland⁸, Jin Seok Kim⁹, H Miles Prince¹⁰, Albert Oriol¹¹, Nizar J. Bahlis¹², Ajai Chari¹³, Christopher Chiu¹⁴, David Soong¹⁴, Jon Ukropec¹⁵, Ming Qi¹⁴, Jesus San-Miguel¹⁶ (1.Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan, 2.Winship Cancer Institute, Emory University, Atlanta, GA, United States of America, 3.The National and Kapodistrian University of Athens, Athens, Hellenic Republic, 4.Sheba Medical Center, Tel Hashomer, Ramat Gan, State of Israel, 5.Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, 6.Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 7.Hematology, University Hospital Hôtel-Dieu, Nantes, France Metropolitan, 8.Leukemia/Bone Marrow Transplant Program, University of British Columbia, Vancouver, British Columbia, Canada, 9.Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea, 10.Cabrini Hospital, Epworth HealthCare and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia, 11.Institut Català d’Oncologia i Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain, 12.University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, Calgary, AB, Canada, 13.Icahn School of Medicine at Mount Sinai, New York, NY, United States of America, 14.Janssen Research & Development, LLC, Spring House, PA, United States of America, 15.Janssen Global Medical Affairs, Horsham, PA, United States of America, 16.Clínica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain)

Kota Sato, Tadao Ishida, Junichiro Nashimoto, Yui Uto, Kanji Miyazaki, Mizuki Ogura, Yumiko Yoshiki, Yu Abe, Kiyoshi Okazuka, Nobuhiro Tsukada, Kenshi Suzuki (Division of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)

Nizar J. Bahlis¹, Maria-Victoria Mateos², Hareth Nahi³, Wojciech Legiec⁴, Vladimir Vorobyev⁵, Ivan Spicka⁶, Vania Hungria⁷, Sibirina Korenkova⁸, Max Flogegard⁹, Joan Blade¹⁰, Philippe Moreau¹¹, Martin Kaiser¹², Shinsuke Iida¹³, Jacob Laubach¹⁴, Tahamtan Ahmadi¹⁵, Pamela L. Clemens¹⁶, Tara Masterson¹⁶, Kristen Lantz¹⁶, Lisa O‘Rourke¹⁶, Christoph Heuck¹⁶, Lixian Peng¹⁷, Dolly A. Parasrampuria¹⁶, Zhilong Yuan¹⁷, Ming Qi¹⁶, Saad Z. Usmani¹⁸ (1.University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada, 2.University Hospital of Salamanca/IBSAL, Salamanca, Spain, 3.Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Kingdom of Sweden, 4.Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Republic of Poland, 5.S.P. Botkin City Clinical Hospital, Moscow, Russian Federation, 6.General Faculty Hospital, Prague, Czech Republic, 7.Clinica São Germano, São Paulo, Federative Republic of Brazil, 8.Kiev Center for Bone Marrow Transplantation, Kiev, Ukraine, 9.Department of Internal Medicine, Falun General Hospital, Falun, Kingdom of Sweden, 10.IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, 11.University Hospital of Nantes, Nantes, France Metropolitan, 12.Division of Molecular Pathology, Institute of Cancer Research, Sutton, United Kingdom of Great Britain and Northern Ireland, 13.Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 14.Department of Hematology and Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America, 15.Genmab US, Inc., Princeton, NJ, United States of America, 16.Janssen Research & Development, LLC, Spring House, PA, United States of America, 17.Janssen Research & Development, LLC, Raritan, NJ, United States of America, 18.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America)